@article{6859f7676c5147039e2202b552f82fd8,
title = "Giving failed drugs a fresh chance: A new direction for nanoparticle drug delivery",
keywords = "failed therapeutics, nanomedicine, nanoparticle drug delivery",
author = "Wang, {Andrew Z.}",
note = "Funding Information: AZ Wang has a consulting agreement with Samyang Biopharmaceuticals Corporation. He is also the cofounder of Coordination Therapeutics, Inc. AZ Wang is also supported by NIH/National Cancer Institute K12 Career Development Award 5-K12-CA120780-01-05 and UL1TR000083, and NIH Center for Nanotechnology Excellence Grant 1-U54-CA151652-01. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest or financial conflict with the subject matter or materials discussed in the manuscript, apart from those disclosed.",
year = "2012",
month = sep,
doi = "10.1586/erd.12.50",
language = "English (US)",
volume = "9",
pages = "445--447",
journal = "Expert review of medical devices",
issn = "1743-4440",
publisher = "Expert Reviews Ltd.",
number = "5",
}